Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
January 24, 2017 – The FDA announced the discontinuation of Enjuvia (synthetic conjugated estrogens, B) due to business reasons.
Download PDF
Return to publications
